Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration (2016)
- Authors:
- Autor USP: RONSEIN, GRAZIELLA ELIZA - IQ
- Unidade: IQ
- DOI: 10.1161/CIRCRESAHA.116.308357
- Subjects: APOLIPOPROTEÍNAS; ARTERIOSCLEROSE; DOENÇAS CARDIOVASCULARES
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphyia
- Date published: 2016
- Source:
- Título: Circulation Research
- ISSN: 0009-7330
- Volume/Número/Paginação/Ano: v. 119, n. 1, p. 83-90, 2016
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
MONETTE, Jeffrey S et al. Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration. Circulation Research, v. 119, n. 1, p. 83-90, 2016Tradução . . Disponível em: https://doi.org/10.1161/CIRCRESAHA.116.308357. Acesso em: 28 dez. 2025. -
APA
Monette, J. S., Hutchins, P. M., Ronsein, G. E., Wimberger, J., Irwin, A. D., Tang, C., et al. (2016). Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration. Circulation Research, 119( 1), 83-90. doi:10.1161/CIRCRESAHA.116.308357 -
NLM
Monette JS, Hutchins PM, Ronsein GE, Wimberger J, Irwin AD, Tang C, Sara JD, Shao B, Vaisar T, Lerman A, Heinecke JW. Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration [Internet]. Circulation Research. 2016 ; 119( 1): 83-90.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1161/CIRCRESAHA.116.308357 -
Vancouver
Monette JS, Hutchins PM, Ronsein GE, Wimberger J, Irwin AD, Tang C, Sara JD, Shao B, Vaisar T, Lerman A, Heinecke JW. Patients with coronary endothelial dysfunction have impaired cholesterol efflux capacity and reduced HDL particle concentration [Internet]. Circulation Research. 2016 ; 119( 1): 83-90.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1161/CIRCRESAHA.116.308357 - Niacin therapy increases high-density lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects
- Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients
- Diabetes impairs cellular cholesterol efflux from ABCA1 to small HDL particles
- Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway
- Targeted proteomics identifies Paraoxonase/Arylesterase 1 (PON1) and apolipoprotein Cs as potential risk factors for hypoalphalipoproteinemia in diabetic subjects treated with fenofibrate and rosiglitazone
- HDL proteome: from its characterization to quantitative measurements in particle subspecies and functional associations
- Niacin increases atherogenic proteins in high-density lipoprotein of statin-treated subjects
- Time to ditch HOL-C as a measure of PINION HOL function?
- Inflammation, remodeling, and other factors affecting HDL cholesterol efflux
- Investigating the relationship between High-Density Lipoprotein (HDL) and endothelial cells
Informações sobre o DOI: 10.1161/CIRCRESAHA.116.308357 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
